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Introduction
General practitioners (GPs) are faced with patients who present
many different types of medical, social and general problems. A
typical consultation in general practice involves identifying the
patient’s presenting problem, hypothesising possible aetiologies,
examination, performing and arranging investigations, decisions
on further management, addressing preventative medical issues,
and sometimes referral for specialist advice or care – all within
time slots of 6 to 12 minutes.1 Another challenge is to identify
those patients in need of immediately necessary treatment as
opposed to those who could be investigated and treated over a
number of subsequent consultations.   
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Abstract
Introduction: The identification and management of adults presenting with pneumonia is a major challenge for primary care health
professionals. This paper summarises the key recommendations of the British Thoracic Society (BTS) Guidelines for the management of
Community Acquired Pneumonia (CAP) in adults. 
Method: Systematic electronic database searches were conducted in order to identify potentially relevant studies that might inform
guideline recommendations. Generic study appraisal checklists and an evidence grading from A+ to D were used to indicate the strength
of the evidence upon which recommendations were made.
Conclusions: This paper provides definitions, key messages, and recommendations for handling the uncertainty surrounding the clinical
diagnosis, assessing severity, management, and follow-up of patients with CAP in the community setting. Diagnosis and decision on
hospital referral in primary care is based on clinical judgement and the CRB-65 score. Unlike some other respiratory infections (e.g. acute
bronchitis) an antibiotic is always indicated when a clinical diagnosis of pneumonia is made. Timing of initial review will be determined
by disease severity. When there is a delay in symptom or radiographic resolution beyond six weeks, the main concern is whether the CAP
was a complication of an underlying condition such as lung cancer.
© 2010 Primary Care Respiratory Society UK. All rights reserved.
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It is essential that potentially life-threatening illnesses such as
Community Acquired Pneumonia (CAP) are diagnosed and
managed rapidly, yet given the nature of primary care
consultations, the identification and management of adults
presenting with pneumonia is a major challenge for primary care
health professionals. 
The British Thoracic Society (BTS) CAP Guidelines,
published in October 2009,2 provide comprehensive detailed
evidence-based information on the management of CAP in
adults. Systematic electronic database searches were
conducted in order to identify potentially relevant studies that
might inform guideline recommendations. Generic study
appraisal checklists and an evidence grading from A+ to D
were used to indicate the strength of the evidence upon
which recommendations were made. Of note, the Guidelines
do not apply to patients who are immunosuppressed, nor do
they apply to the larger group of adults with non-pneumonic
lower respiratory tract infection – which includes illnesses
labelled as acute bronchitis, acute exacerbations of COPD, or
“chest infections”.    
In order to promote wider dissemination in primary care, and
with permission from the publisher and editors of Thorax, this
paper summarises the key recommendations from the full BTS
Guidelines, and draws together recommendations and text
relevant to primary care. It has been endorsed by both the Royal
College of General Practitioners (RCGP) and the Primary Care
Respiratory Society UK (PCRS-UK). 
The evidence grading system used in developing the full
Guidelines is shown in Table 1, and in this summary paper the
evidence grading is shown in blue adjacent to the appropriate
text or reference number. 
Definition
For the purpose of these Guidelines,2 community acquired
pneumonia (CAP) has been defined as:
• Symptoms of an acute lower respiratory tract illness (cough
and at least one other lower respiratory tract symptom) 
• New focal chest signs on examination
• Evidence of systemic illness (temperature >38°C and/or the
symptom complex of sweating, fevers, shivers, aches and
pains).
• No other explanation for the illness, and a clinical decision that
it should be treated as community acquired pneumonia with
antibiotics. 
Burden of disease
In prospective population studies, the annual incidence of CAP in
the community has been reported as 5-11 per 1000 adult
population.3-5 Pneumonia, diagnosed clinically by GPs, accounts
for only 5–12% of all cases of adult lower respiratory tract
infection treated with antibiotics by GPs in the community in the
UK.3,6 In the UK, 22-42% of adults with CAP are admitted to
hospital.3,7
The reported mortality of adults with CAP managed in the
community in the UK is very low and less than 1%.3,8,9 The direct
costs associated with CAP are high and are mostly associated with
inpatient care costs.7
Streptococcus pneumoniae is the commonest causative
organism in CAP in all ages, accounting for about 36% of cases
of CAP diagnosed in the community.10 Mycoplasma pneumoniae
and legionella infection are less frequent in the elderly,11,12 while
Haemophilus influenzae may be more commonly identified in the
elderly.13
Prevention and vaccination
Cigarette smoking, both active and passive, is a recognised
independent risk factor for CAP.14,15[Ib] Dose-response
relationships with the current number of cigarettes smoked per
day, pack-years of smoking, and time since quitting, have all been
demonstrated in relation to invasive pneumococcal disease.15,16[III]
Recommendations: 
• Smoking cessation advice should be offered to all 
patients with community acquired pneumonia who
are current smokers, according to smoking 
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Evidence level Definition Guideline statement grade
Ia A good recent systematic review of studies designed to answer the question of interest A+
Ib One or more rigorous studies designed to answer the question, but not formally combined A-
II One or more prospective clinical studies which illuminate, but do not rigorously answer, the question B+
III One or more retrospective clinical studies which illuminate, but do not rigorously answer, the question B-
IVa Formal combination of expert views C
IVb Other information D
Table 1. Brief description of the generic levels of evidence and guideline statement grades used. 
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cessation guidelines issued by the Health 
Education Authority.17[B+]
• Department of Health guidelines in relation to 
influenza and pneumococcal immunisation of ‘at-risk’ 
individuals should be followed. [C]
Diagnosis of community acquired
pneumonia in the community
In the UK, most CAP is managed in primary care, where access to
rapid chest radiography is limited. Consequently, in contrast with
the hospital setting – where the diagnosis of CAP is confirmed by
chest radiographic features – diagnosis in the community will
often be based only on the clinical features. In this challenging
setting, clinicians have to differentiate those patients presenting
with CAP from the majority of patients who have acute, non-
pneumonic lower respiratory tract infections or other
diagnoses.4,18[Ib] 
The typical patient history of cough, fever and dyspnoea with
chest pains, and lung crackles on examination, is not reliable in
discriminating CAP from other acute lower respiratory tract
infections.19[II] 20[Ia] 21[Ia]
Various prediction rules have been published for the diagnosis
of CAP, but generally these have shown the need for confirmatory
radiographic evidence. Nevertheless, some helpful pointers in the
diagnosis of CAP have been reported:
a) Woodhead et al.3[II] reported that in adults treated with
antibiotics for an acute lower respiratory tract infection
associated with new focal signs on chest examination, 39%
had evidence of CAP on chest radiograph. 
b) Melbye et al.19[II] found that, of the clinical findings reported
by GPs to be most suggestive to them of CAP, only a short
duration of symptoms (<24 h) was of significant predictive
value. 
c) In a study of 1819 adults presenting to hospital outpatients
with acute cough, Diehr et al.22[II] showed that the presence of
fever (>37.8°C), raised respiratory rate (>25 breaths/min),
sputum production throughout the day, myalgia and night
sweats, plus the absence of sore throat and rhinorrhoea,
predicted CAP in a diagnostic rule with 91% sensitivity and
40% specificity. 
d) Another study conducted in patients presenting with acute
respiratory symptoms to outpatient clinics and the emergency
department in California determined that the presence of
either abnormal vital signs (fever >38°C, tachycardia
>100/min and tachypnoea >20/min) or an abnormal physical
examination of the chest (crackles, decreased breath sounds,
dullness to percussion, wheeze) identified patients with
radiographically confirmed CAP with a sensitivity of 95%,
negative predictive value of 92% and specificity of 56%.23[II]
e) In elderly patients, the classic symptoms and signs of
pneumonia are less likely, and non-specific features –
especially confusion – are more likely.24-28[II] In addition,
absence of fever is more common compared to younger
patients with CAP.29,30[II]
In practice, GPs manage the vast majority of patients
pragmatically at first presentation. The important decision in
patients presenting with a lower respiratory tract infection, or
suspected CAP, is deciding whether to use an antibiotic, which
one, and how ill the patient is. Labelling the illness as pneumonia
is less important.31
Severity assessment and site of care
The decision regarding the most appropriate site of care – in
particular, whether hospitalisation of a patient with CAP is
warranted – is the first and single most important decision in the
overall management of CAP. It has consequences on both the
level of treatment received by the patient as well as the overall
costs of treatment.7[III] This decision is best informed firstly by an
accurate assessment of the severity of illness at presentation (and
hence the likely prognosis), and secondly by other factors such as
the stability of other co-morbid illnesses and the social
circumstances of the patient. 
The CRB-65 score
The clinical judgement of the GP will be crucial in assessing
the severity of illness, but this can be aided by the simple CRB-
65 severity assessment tool. The CRB-65 score is a practical,
validated tool which provides a clinician in a community
setting with an assessment of the severity of CAP based on
mortality risk.32,33 The score is based on the presence of
confusion,34 raised respiratory rate, low blood pressure and
the age of the patient (see Figure 1). 
The recognition of patients at low risk of complications – who
are therefore suitable for treatment outside hospital – has the
potential to reduce inappropriate hospitalisation and consequently
inherent morbidity and costs. Ultimately, the decision to manage
a patient in the community is based on a range of factors which
include an assessment that the pneumonia is of low severity, that
oral therapy is appropriate and will be complied with, and that the
social circumstances and available care for an individual are
satisfactory.
Recommendations:
• For all patients, clinical judgement should be 
supported by the CRB-65 score (see Figure 1) when 
deciding whether to treat the patient at home or in 
hospital. [D] 
• Patients who have a CRB-65 score of 0 are at low risk 
of death and do not normally require hospitalisation 
for clinical reasons. [B+]
• Patients who have a CRB-65 score of 1 or 2 are at 
increased risk of death, particularly those patients 
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with Score 2, and hospital referral and assessment 
should be considered. [B+]
• Patients who have a CRB-65 score of 3 or more are at 
high risk of death and require urgent hospital 
admission. [B+]
• When deciding on home treatment, the patient’s social
circumstances and wishes must be taken into account 
in all instances. [D]
Investigations
General investigations may be performed for the following
reasons: to assess severity; to assess the impact on, or to detect
the presence of, any co-morbid disease; to provide some pointer
to the particular aetiological agent or group of pathogens; to
identify complications; and to monitor progress. Pulse oximeters
allow for simple assessment of oxygenation. 
Most patients with pneumonia are treated successfully in the
community in the absence of any microbial definition of an
infecting micro-organism(s). Many microbiological investigations
will not be appropriate for patients with CAP managed in the
community. Such patients are not usually severely ill, are at low risk
of death, and delays in transport of specimens to the laboratory
reduces the yield of bacterial pathogens (especially S pneumoniae)
from sputum cultures. Results are also often received too late by
the GP for them to be of much practical value in initial
management.
PRIMARY CARE RESPIRATORY JOURNAL
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Figure 1.  Severity assessment of community acquired pneumonia in the community (adapted from ref 34).
Patient presents with symptoms suggestive of a lower respiratory
tract infection (cough plus another respiratory symptom)
Clinical diagnosis of CAP
Treat according to clinical judgement
and CRB-65 severity score
CRB-65 severity score32:
1 point for each feature present:
● Confusion*
● Respiratory rate ≥30/min
● Blood pressure (SBP <90 or DBP ≤60mmHg)
● Age ≥ 65 years
Not CAP. Reconsider
other diagnoses and
need for investigations
1-2
Moderate severity
0
Low severity
3-4
High severity
Likely suitable
for home
treatment
Oral antibiotics
Consider
hospital
referral
Urgent hospital
admission
Empirical antibiotics
if life-threatening
Consider social circumstances and home support
when deciding on whether to refer to hospital or
manage in the community
ABBREVIATED MENTAL TEST34 (each question scores 1 mark, total 10 marks)
Age
Recognition of two persons (eg doctor, nurse)
Date of birth
Recall address (eg 42 West Street)
Time (to nearest hour)
Date of First World War
Year
Name of Monarch
Address or location (“Where are you?”)
Count backwards 20 - 1
*A score of 8 or less has been used to define mental confusion in the CRB-65 severity score
SBP = systolic blood pressure; DBP = diastolic blood pressure
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Recommendations:
• General investigations (like full blood counts) are not 
necessary for the majority of patients with community 
acquired pneumonia who are managed in the 
community. [C] 
• Pulse oximetry, with appropriate training, should be 
available to GPs and other clinicians responsible for the 
assessment of patients in the out-of-hours setting for 
the assessment of severity and oxygen requirement in 
patients with CAP and other acute respiratory illnesses. 
[D] 
• Patients without pre-exisiting co-morbid medical 
conditions who have an oxygen saturation <94% 
should be considered for hospital referral and oxygen 
supplementation.35
• Pulse oximetry should be available in all locations 
where emergency oxygen is used. [D]
• For patients managed in the community 
microbiological investigations are not recommended 
routinely. [D] 
• Examination of sputum should be considered for 
patients who do not respond to empirical antibiotic 
therapy. [D]
• Examination of sputum for Mycobacterium 
tuberculosis should be considered for patients with a 
persistent productive cough, especially if they have 
malaise, weight loss or night sweats, or if risk factors 
for tuberculosis (e.g. ethnic origin, social deprivation, 
the elderly) are present. [D]
• Urine antigen investigations (for S pneumoniae or 
Legionella pneumophilia), PCR of upper (e.g. nose 
and throat swabs) or lower (e.g. sputum) respiratory 
tract samples, or serological investigations (for a 
range of respiratory viruses and some atypical 
pathogens such as Mycoplasma pneumoniae) may be
considered during outbreaks (e.g. Legionnaires’ 
disease), during mycoplasma epidemic years, or when
there is a particular clinical or epidemiological 
reason. [D]
Chest X Ray
• It is not necessary to perform a chest radiograph in 
patients with suspected CAP unless:
a) The diagnosis is in doubt and a chest radiograph 
will help in the differential diagnosis and 
management of the acute illness. [D]
b) Progress following treatment for suspected CAP is 
not satisfactory at review. [D] 
c) The patient is considered at risk of underlying lung 
pathology. [D] 
General and antibiotic management
Unlike some other respiratory infections (e.g. acute bronchitis),36
an antibiotic is always indicated when a clinical diagnosis of
pneumonia is made. Empirical therapy is primarily directed at S
pneumoniae which remains the leading cause of CAP. [Ia]
From time to time, GPs see patients who are severely ill
with what appears to be pneumonia. There is direct and
indirect evidence that administering antibiotics early is
important in the outcome of CAP, particularly when the
patient is assessed as being severely ill.37-39[Ib] In the UK, less
than half of patients admitted with high severity CAP have
received antibiotics from their GP.40,41[III] Prescribing antibiotics
does have an influence on some microbiological
investigations.42[Ib] However, when GPs feel that a patient is
severely ill, or circumstances suggest that delays in transfer
will slow assessment and treatment in hospital, concern over
the potential effect on subsequent investigations is not a
reason to withhold treatment.
Recommendations: 
• Patients with suspected CAP should be advised not to 
smoke, to rest, and to drink plenty of fluids. [D] 
• Pleuritic pain should be relieved using simple analgesia 
such as paracetamol. [D]
• For patients treated in the community, amoxicillin 
remains the preferred agent at a dose of 500 mg three 
times daily. [A+]
• Either doxycycline (200mg loading dose then 100 mg 
daily) [D] or clarithromycin (500 mg twice daily) [A-]
are appropriate as an alternative choice, and for those 
patients who are hypersensitive to penicillins. 
• For patients managed in the community, seven days of 
appropriate antibiotics is recommended. [C]
• For those patients referred to hospital with suspected 
CAP and where the illness is considered to be life-
threatening, GPs should administer antibiotics in the 
community. [D] Penicillin G 1.2g intravenously or 
amoxicillin 1g orally are the preferred agents.
• For those patients referred to hospital with suspected 
high severity CAP and where there are likely to be 
delays of over six hours in the patient being admitted 
and treated in hospital, GPs should consider 
administering antibiotics in the community. [D]
Patient review and follow-up
arrangements 
Patients should be informed about the expected rate of resolution
of their symptoms and any X-ray changes that have been found
(in those who had this investigation). In most patients, symptoms
and chest X-ray abnormalities resolve within six weeks. In the
elderly, radiographic clearance is slower. 
25
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When to review a patient with CAP in the community will be
determined by the initial severity assessment and other factors
such as the help available in the home setting. Patients assessed as
being at low severity should improve on appropriate therapy
within 48 hours, at which time severity reassessment is
recommended. Those who fail to improve within 48 hours should
be considered for hospital admission. Patients who do not fulfil the
criteria for low severity and are being managed at home will
require more frequent review.
For patients discharged from hospital, it is usual practice to
arrange ‘‘routine’’ hospital clinic follow-up and repeat the chest
radiograph at around six weeks after discharge. However, there is
no evidence on which to base a recommendation regarding the
value of this practice in patients who have otherwise recovered
satisfactorily. It is also not known whether there is any value in
arranging clinical follow-up in a hospital clinic rather than with the
patient’s GP. The main concern is whether or not the CAP was a
complication of an underlying condition such as lung cancer.
Therefore, it seems sensible to arrange a clinical review of all
patients at around six weeks, either with their GP or in a hospital
clinic. If clinical or radiographic resolution is delayed, referral to a
specialist may be appropriate.
Recommendations:
• Review of patients in the community with CAP is 
recommended after 48 hours, or earlier if clinically 
indicated. Disease severity assessment should form part
of the clinical review. [D]
• Those who fail to improve after 48 hours of treatment 
should be considered for hospital admission or chest 
radiography. [D]
• For patients discharged from hospital, it is the 
responsibility of the hospital team to arrange the 
follow-up plan with the patient and the GP. [D] 
• At discharge or at follow-up, patients should be offered
access to information about CAP such as a Patient 
Information Leaflet (PIL). [D] A PIL on CAP is available 
on request from the British Lung Foundation 
Headquarters (British Lung Foundation, Freepost 
SW1233, London EC1B 1BR) and British Lung 
Foundation UK regional offices, or from the Clinical 
Knowledge Summaries (CKS) webpage provided by the
NHS Institute for Innovation and Improvement. 
[http://www.cks.nhs.uk/patient_information_leaflet/ 
pneumonia] 
Conclusions
This summary of the BTS CAP Guidelines originally published in
October 20092 provides definitions, summaries of key messages,
and recommendations for handling the uncertainty of the clinical
diagnosis, assessing severity, management, and follow-up of
patients with CAP in the community setting. Diagnosis and
decision on hospital referral in primary care should be based on
clinical judgement and the CRB-65 score. An antibiotic is always
indicated when a clinical diagnosis of pneumonia is made. When
there is delay in symptom or radiographic resolution beyond six
weeks, the main concern is whether the CAP was a complication
of an underlying condition such as lung cancer. 
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